FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.

2.

Q&A: How early cancer screening could save Canada nearly half a billion dollars over patients' lifetimes

3.

Can taking vitamin D supplements every day lower the mortality rate from cancer?

4.

Elder Abuse: Red Flags to Look Out For While Receiving Care.

5.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot